Aptevo Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $902 |
Gross Profit | -91 | -106 | 786 | |
EBITDA | -5,129 | -5,933 | -6,877 | -6,268 |
EBIT | -5,213 | -6,024 | -6,983 | -6,384 |
Net Income | -5,101 | -5,883 | -6,834 | -5,903 |
Net Change In Cash | 0 | 0 | 0 | 902 |
Free Cash Flow | -5,222 | -6,153 | -6,651 | -5,253 |
Cash | 7,753 | 8,066 | 10,250 | 16,904 |
Basic Shares | 285 | 3,519 | 686 | 498 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $3,114 | $12,292 | $4,309 |
Gross Profit | -567 | 2,213 | 12,292 | -13,543 |
EBITDA | -28,311 | -27,740 | -20,256 | -26,088 |
EBIT | -28,878 | -28,641 | -21,400 | -27,494 |
Net Income | -17,411 | 42,669 | -27,313 | -18,448 |
Net Change In Cash | 0 | 3,114 | 12,292 | 4,309 |
Free Cash Flow | -11,730 | -21,051 | -22,392 | -29,406 |
Cash | 16,904 | 22,635 | 45,044 | 39,979 |
Basic Shares | 278 | 115 | 106 | 77 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.48 |
2024-06-30 | -$1.67 |
2024-03-31 | -$9.95 |
2023-12-31 | -$6.16 |
